NCT05316311 - A Study of Implantation of CRENEOUS ENTERPRISE 2 Intracranial Stent in Participants With Severe Symptomatic Intracranial Atherosclerotic Stenosis | Biotech Hunter

Enrollment

194

Participants

Timeline

Start Date

May 24, 2022

Primary Completion Date

February 10, 2026

Study Completion Date

April 11, 2026

Conditions

Intracranial Atherosclerosis

Interventions

DEVICE

CERENOVUS ENTERPRISE 2 Intracranial Stent

CERENOVUS ENTERPRISE 2 Intracranial Stent will be used to treat severe symptomatic intracranial artery stenosis.

Trial Locations (14)

RECRUITING

Xuanwu Hospital, Capital Medical University, Beijing

RECRUITING

West China Hospital of Sichuan University, Chengdu

RECRUITING

Haikou People's Hospital, Haikou

RECRUITING

First Affiliated Hospital, Harbin Medical University, Harbin

RECRUITING

Central Hospital Affiliated to Shandong First Medical University (Jinan Central Hospital), Jinan

RECRUITING

Qilu Hospital of Shandong University, Jinan

RECRUITING

Shandong Provincial Hospital, Jinan

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

RECRUITING

Ningbo First Hospital, Ningbo

RECRUITING

Huashan Hospital Fudan University, Shanghai

RECRUITING

Wenzhou Central Hospital, Wenzhou

RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

RECRUITING

The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou